n South African Pharmaceutical and Cosmetic Review - To comply or not to comply? : pharmaceutical focus




Henry Paulson the former United States Secretary of the Treasury made the statement: 'Regulation needs to catch up with innovation'. The Government notice R. 870, referring to the General Regulations made in terms of the Medicines and Related Substances Act, published on 15 November 2013, had a serious impact on product innovation for products falling into the CAMs sector. It classified all CAMs products as Category D medicines, which needed to be registered as such.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error